Want to stay abreast of changes in prevention, care, treatment or research or other public health arenas that affect our collective response to the HIV epidemic? Or are you new to this field?
HIV.gov curates learning opportunities for you, and the people you serve and collaborate with.
Stay up to date with the webinars, Twitter chats, conferences and more in this section.
01-22-2021@US_FDA has approved Cabenuva (cabotegravir and rilpivirine), the first injectable, complete treatment regimen for people with #HIV that is administered once a.…
12-07-2020As we look back on World AIDS Day 2020, our colleagues across the federal government spoke out about progress to date in our collective response to HIV and reco…
05-05-2020On May 1, 2020, the President announced that the investigational antiviral drug remdesivir has been authorized by the U.S. Food and Drug Administration for emer…
10-03-2019The FDA today approved Descovyin at-risk adults and adolescents weighing at least 35kg for HIV-1 pre-exposure prophylaxis (PrEP) to reduce the risk of HIV...
04-09-2019The FDA approved Dovato, the first FDA-approved two-drug, fixed-dose, complete regimen for HIV-infected adults who have never received treatment for HIV.
12-03-2018World AIDS Day is always a busy time for the HIV community. For your convenience, we have recapped some of our 2018 World AIDS Day blog posts.